Position in IDXX
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$2,105
-$142 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,257
of 1,286 holders
Holding Since
Dec 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Byrne Asset Management LLC holds $2,294,324 across 8 Diagnostics & Research names. IDXX ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
5,078 | $1,076,282 | |
| 2 | RVTY |
Revvity, Inc.
|
7,646 | $850,693 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
421 | $211,072 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
583 | $112,647 | |
| 5 | WAT |
Waters Corp /De/
|
75 | $28,128 | |
| 6 | DHR |
Danaher Corp /De/
|
37 | $7,047 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
28 | $6,350 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
This page
|
4 | $2,105 |
All Filings in IDXX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,105 | 4 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $2,247 | 4 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $2,706 | 4 | Shares | Sole | 2026-01-12 | |
| 2022-03-31 | $77,682 | 142 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $133,008 | 202 | Shares | Sole | 2022-02-22 | |
| No filing history on record for this holder in this stock. | ||||||